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Objective: The goal of the study was to investigate the expression of cadherin-11 in synovial ﬁbroblasts
(SFs) under mechanical or inﬂammatory stimuli, and its potential relationship with PI3K/Akt signaling
pathway.
Methods: SFs separated from rat temporomandibular joint (TMJ) were treated with hydrostatic pressures
(HP) of 30, 60, 90, and 120 kPa, as well as tumor necrosis factor-a (TNF-a) for 12, 24, 48, and 72 h. The
location of cadherin-11 was observed by immunoﬂuorescence microscopy, and its expression was
detected by real-time PCR and Western blot. We also studied the activation of PI3K/Akt signaling
pathway in SFs with HP or TNF-a stimulation.
Results: The results showed that increased expression of cadherin-11 could be found in the cellecell
contact site of SFs in response to HP and inﬂammatory stimulation. The mRNA and protein expression of
cadherin-11 was positively correlated with the intensity of HP and the duration time of TNF-a treatment.
Increased expression of vascular endothelial growth factor-D (VEGF-D) and activation of Akt were also
found. Treatment with PI3K inhibitor LY294002 attenuated the pressure or inﬂammatory cytokine in-
duction increases of cadherin-11, VEGF-D, and FGF-2 both in mRNA and protein levels.
Conclusions: These ﬁndings suggest that cadherin-11 may play important roles in SFs following exposure
to mechanical loading and inﬂammatory stimulation. In addition, PI3K/Akt pathway was associated with
pressure or inﬂammation-induced cadherin-11 expression, which may involve in the pathogenesis of
temporomandibular diseases.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The prevalence of temporomandibular disorders (TMD) varied
from 5% to 86% depending on different epidemiological studies,
diagnostic criteria, and the means of assessment1,2. Although
remarkable progress has been made in past three decades, the eti-
ology and pathogenesis of TMD still remains uncertain, which
brought difﬁculty to the diagnostic and mechanism-based phar-
macotherapy. Usually, mandibular condylar cartilage would suffer
the pressures by frequent jaw movement and biting hard food.
Abnormal elevated intra-articular pressure and local inﬂammation
may alter the stability of joint cavity and the compositionalZ. Gu, School of Stomatology,
ad, Hangzhou 310053, China.
s Research Society International. Pproperties of the ﬁbro cartilage. It may also subsequently induce
dysfunctional remodeling and cartilage breakdown3. It has been
suggested that mechanical loading triggered production of cyto-
kines and pro-inﬂammatory factors, matrix-degrading enzymes,
and other bioactivemolecules involved in the development of TMD4.
Differentially expression of cytokines monocyte chemoattractant
proteine1 (MCP-1), IL-1ra, and IL-8 was found in TMD patients as
well as the elevated levels of cytokine receptors in synovial ﬂuids5,6.
Zhou YH et al. also showed that degenerative change of temporo-
mandibular joint (TMJ) synovium upon sustained inﬂammation is a
predisposing factor for TMJ degeneration in rat model7. However,
the molecular mechanism by which TMJ synovium participated in
the TMJ degeneration under overloading was not known.
Cadherin-11, expressed in synovium and other mesenchymal
tissues, has been identiﬁed to participate cartilage invasion expect
for its adhesive function8. The strength of the cadherin mediated
cellecell interaction could be altered by the certain specialublished by Elsevier Ltd. All rights reserved.
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in evoking synovial ﬁbroblasts (SFs) inﬂammatory factors that may
contribute to rheumatoid arthritis (RA) in vitro and in hind ankle
joints of mice10. It was also suggested that cadherin-11 on
ﬁbroblast-like synoviocytes contributed to synovial inﬂammation
and cartilage degradation, which may be a potential therapeutic
target for RA11. However, expression of cadherin-11 in SFs of TMJ
undermechanical loading or inﬂammatory stimuli is rarely studied.
Therefore, an understanding of the role of cadherin-11 on patho-
genesis of TMD is essential to the successful future clinical man-
agement of patients.
In this study, we describe the change of cadherin-11 expression
and its location under the mechanical loading and inﬂammatory
stimulation. The effects of PI3K/Akt signal transduction pathway on
cadherin-11production were investigated in mRNA and protein
level.Materials and methods
Isolation and culture of SFs
Synovial tissue was harvested from the TMJ of ﬁve male Spra-
gueeDawley rats (6-week-old, obtained from the Zhejiang Center
of Laboratory Animals, China) according to a described procedure
with minor modiﬁcations12. The protocol was approved by the
Animal Care and Use Committee at the Zhejiang University. Brieﬂy,
surface parts of the synovial tissues were isolated from TMJ of each
rat, followed by extensive washing with phosphate-buffered saline
(PBS). The tissue parts were minced into 1 mm3 pieces and plated
onto tissue culture dishes with a medium consisting of Dulbecco’s
modiﬁed Eagle medium (Gibco, NY, USA) supplemented with 4 mM
L-glutamine (Irvine Scientiﬁc), antibiotics (100 unit/mL penicillin,
SigmaeAldrich, St. Louis, MO and 50 mg/ml gentamicin, Invitrogen
Life Technologies), and 15% heat-inactivated fetal calf serum (Gibco,
NY, USA). When cells grown from the explants reached conﬂuency,
all SFs from different donor animals were trypsinized and sub-
cultured together in 75 cm2 culture ﬂasks. The morphology of SFs
was conﬁrmed by immunocytochemical staining detected with
marker proteins CD68 and vimentin (macrophage and ﬁbroblasts
markers, respectively)13.Treating SFs with pressure loading and inﬂammatory stimulation
Isolated SFs were seeded at a density of 1  105 cells/cm2 in 6-
well plates and incubated overnight in DMEM with 10% FBS. Prior
to the treatment, the serum-containing medium of SFs was
removed and serum-free medium was added. After synchroniza-
tion in the serum-free culture medium for 24 h, the regular me-
diumwas replaced and SFs were treated with hydrostatic pressures
(HP), TNF-a, and PI3K/Akt inhibitor.Fig. 1. Location of cadherin-11 in SFs observed by immunoﬂuorescence microscopy. A: CoFor HP loading, each culture plate was transferred into a
stainless-steel chamber (SASPG Medical Equipment Factory,
Sichuan Province, China) ﬁlled with pre-warmed sterilized distilled
water. The illustration of the pressured chamber can be found in
Fig. 1 of our previous report14. Brieﬂy, it was designed according to
the apparatus of Smith RL and Yamamoto T et al. with minor
modiﬁcations15,16, which allows sterile manipulation and can apply
up to 150 kPa of HP to cultured cells at a constant level. The
chamber was situated in a humidiﬁed incubatormaintained at 37C
in 5% CO2. HP was designed and applied to the cultures for 12 h at
30, 60, 90, and 120 kPa according to the results of preliminary
experiment. Unpressurized samples were placed in a separate
pressure vessel under the same culture condition without loading
pressure.
For TNF-a treatment, each culture plate was treated by the re-
combinant human TNF-a (R&D Systems, Minneapolis, MN, USA) for
12, 24, 48 and 72 h at ﬁnal concentrations of 10 ng/ml17,18. Control
cultures containing no cytokines were grown in parallel.
To evaluate the effect of PI3K/Akt on the SFs treated by HP and
TNF-a, SFs were pre-incubated with 10 mM LY294002 for 1 h before
HP and/or TNF-a stimulation for 12 h. The inhibitor was recon-
stituted in dimethylsulphoxide (DMSO), and control cells were pre-
incubated with equivalent amounts of 0.04% DMSO alone.
Actin staining and immunoﬂuorescence
SFs seeded on slide glass with density of 1 105 cells/cm2 were
treated with HP and TNF-a according to the protocol mentioned
above. Cultured cells were incubated with antibody against
cadherin-11 overnight at 4C, followed by incubation with DyLight
594-conjugated goat anti-rabbit secondary antibody (Invitrogen,
Carlsbad, CA) for 30 min. Finally, cells were counterstained with
FITC-phalloidin for 40 min and visualized by immunoﬂuorescence
microscopy (Olympus CX-RFL-2, Tokyo, Japan).
RNA extraction and quantitative real-time PCR analysis
Total RNA was obtained using Trizol reagent (Invitrogen) ac-
cording to the manufacturer’s protocol. The purity and yield of the
isolated RNA were monitored using a NanoDrop spectrophotom-
eter ND 1000 (NanoDrop Technologies, Wilmington, DE). The ﬁrst
strand complementary DNA (cDNA) was synthesized by reverse
transcription using SYBR PrimeScript RT reagent Kit (Takara,
Dalian, China). The samples were diluted in nuclease-free water
and stored at 20C prior to quantitative real-time PCR.
Quantitative real-time RT-PCR was performed using the SYBR
PrimeScript RT-PCR kit (Takara) in the ABI PRISM 7500 Real-Time
PCR System (Applied Biosystems, Foster, CA). Each sample was
ampliﬁed with replicates using speciﬁc primers as follows:
for cadherin-11, forward: 50-AGCCCAATAAGGTATTCAATT-30, reverse:
50-TCACAGATAAAGCCTTCATAAG-30, for vascular endothelial growthntrol. B: Treated with 90 kPa HP for 12 h. C: Treated with TNF-a (10 ng/ml) for 12 h.
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50-TGAGGACATTGATCTTCTT-30, for FGF-1, forward: 50-GAGCGAC
CAGCACATTCAG-30, reverse: 50-GCCCACAAACCAGTTCTTCT-30, for
FGF-2, forward: 50-CTGGCTTCTAAGTGTGTTA-30, reverse: 50-
CAGTGTCTAAAGAGAGTCA-30, for glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH), forward: 50-GAAGGTGAAGGTCGGAGTCG-30,
reverse: 50-GAAGATGGTGATGGGATTTC-30. After an initial denatur-
ation step at 95C for 10 s, ampliﬁcation was performed using 40
cycles of denaturation step at 95C for 10 s, and anneal and extension
at 60C for 34 s. PCR products were calculated in a quantitative
manner with a cycle threshold (Ct) value. Each gene was normalized
against the corresponding GAPDH levels using the DDCT method and
relative gene expression of each sample was shown.
Western blot
Proteins extracted from untreated and treated SFs were quan-
tiﬁed by the modiﬁed Lowry method19. Discontinuous sodium
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
was performed using a Bio-Rad mini-protein II electrophoresis,
and transferred into polyvinylidenediﬂuoride membrane (PVDF,
Amersham Pharmacia Biotech, Piscataway, NJ). Protein extract was
electrophoresed and electroblotted onto supported nitrocellulose
membranes. Blots were blocked for 2 h with 5% non-fat dry milk in
tris-buffered saline (TBS) at room temperature and then incubated
for 1 h with anti-cadherin-11, anti-PI3K, anti-p-PI3K, anti-Akt, anti-
p-Akt, anti-VEGF-D, anti-FGF-1, anti-FGF-2 (Cell Signaling Tech-
nology, Beverly, MA, USA), and anti-GAPDH (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA) speciﬁc primary antibodies (1:1000
dilution) at room temperature for 2 h. Blots were incubated with
HRP-conjugated secondary anti-rabbit antiserum (Santa Cruz, CA,
USA, 1:5000 dilution in TBS). After several washes with 0.1% TBS-
Tween 20, immunoreactive proteins were visualized with an
enhanced chemiluminescence (ECL) and captured on an X-ray ﬁlm.
Protein levels were quantiﬁed using Biosense 300 software (Ober-
haching, Germany). Relative protein expression level was calcu-
lated by comparing to the expression of controls.
Statistics analysis
All statistical analyses were carried out using GraphPad Prism
software (GraphPad, La Jolla, CA, USA). Results are presented asFig. 2. Intensity-dependent effects of HP on cadherin-11 expression of SFs. A: Intensity-dep
effects of HP for 12 h on cadherin-11 protein expression of SFs. Data shows all the values fr
intervals. Exact P-values were computed compared to non-stimulated controls.mean values with 95% conﬁdence intervals. Welch’s corrected t-test
was used for two group comparisons. In the dot plots, exact P-
values are presented for all data sets with signiﬁcant differences.
Results
Observation for the location of cadherin-11 in SFs
The location of cadherin-11 in SFs after treated by HP (90 kPa)
and tumor necrosis factor-a (TNF-a) stimulation (10 ng/ml) for 12 h
were observed. As shown in [Fig. 1(A)], in normal condition, cad-
herin-11 was located in the cell periphery (red ﬂuorescence),
closely connected to the cytoskeleton with ﬁbrous actin ﬁlaments
(green ﬂuorescence). However, in SFs treated with HP and inﬂam-
matory stimulation, cadherin-11 chieﬂy exists in the cellecell
contact site of SFs [Fig. 1(B and C)], respectively, in which the
expression of cadherin-11 was remarkably increased.
Cadherin-11 expression of SFs in response to HP and TNF-a
The mRNA and protein expression of cadherin-11 in SFs treated
with different intensity of HP was evaluated by quantitative real-
time reverse transcription PCR (RT-PCR) and Western Blot. As
shown in [Fig. 2(A)], a dose-dependent increase in cadherin-11
mRNA expression was observed in SFs treated by 30, 60, and
90 kPa with 1.3-(P ¼ 0.0321), 1.9-(P ¼ 0.0038), and 2.5-fold
(P ¼ 0.0088). Expression was decreased to 1.8-fold at 120 kPa, but
still showed signiﬁcant difference in comparison to the control
(P ¼ 0.0049). Cadherin-11 protein expression showed moderate
increase at 30 and 60 kPa, while it was signiﬁcantly increased to
2.3-fold (P¼ 0.0059) and 2.4-fold (P¼ 0.006) when treatedwith HP
of 90 and 120 kPa [Fig. 2(B)].
To assess the variation of cadherin-11 expression in SFs with
inﬂammation stimuli, SFs were treated with TNF-a (10 ng/ml) for 12,
24, 48 and 72 h. The mRNA and protein expression of cadherin-11
expression was quantiﬁed. The results showed a time-course depen-
dent increase of cadherin-11 mRNA expression [Fig. 3(A)]. Compared
with un-treated control, mRNA expression of cadherin-11 was signif-
icantly elevated to approximately 3-fold (P ¼ 0.0023) and 3.4-fold
(P ¼ 0.0012) after incubation with pre-inﬂammatory cytokine TNF-a
for 12 and 24 h. It remained to be an approximately 5-fold increase
after treatment for 48 and 72 h (P ¼ 0.0006). Meanwhile, proteinendent effects of HP for 12 h on cadherin-11 mRNA expression. B: Intensity-dependent
om independent samples of n ¼ 3, and bars represent means with the 95% conﬁdence
Fig. 3. Time-dependent variation of cadherin-11 expression in SFs by TNF-a stimulation (10 ng/ml). A: Cadherin-11 mRNA expression in SFs from 0 to 72 h. B: Cadherin-11 protein
expression in SFs from 0 to 72 h. Data shows all the values from independent samples of n ¼ 3, and bars represent means with the 95% conﬁdence intervals. Exact P-values were
computed compared to non-stimulated controls.
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dependent manner from 12 h to 72 h. As shown in [Fig. 3(B)], treat-
ment of TNF-a in SFs for 12, 24, 48, and 72 h produced signiﬁcant in-
crease in cadherin-11 protein expression by 2.1-, 3.3-fold (P¼ 0.0125),
6.5-fold (P ¼ 0.0108), and 8.3-fold (P ¼ 0.0082), respectively.
Cadherin-11 induction by HP and TNF-a is dependent on PI3K/Akt
signaling
The preliminary study showed that stimulation of HP and TNF-a
could activate the phosphorylation of PI3K and Akt in SFs (data not
shown). To investigate the signaling pathways associated with HPFig. 4. Relative mRNA expression of Cadherin-11 (A), VEGF-D (B), FGF-1 (C), and FGF-2 (D) i
(B) of PI3K inhibitor LY294002. Data shows all the values from independent samples of n
computed compared to non-stimulated controls or cells without LY294002 treatment.and TNF-a induced cadherin-11 expression, we pre-treated SFs
with HP (90 kPa) or TNF-a (10 ng/ml) in absence or presence of PI3K
inhibitor LY294002. Cells cultured without treatment were grown
in DMEM as control.
As shown in Fig. 4, mRNA level of cadherin-11 [Fig. 4(A)], VEGF-
D [Fig. 4(B)], and FGF-2 [Fig. 4(D)] were signiﬁcantly increased both
in HP or TNF-a stimulation. However, mRNA expression of FGF-1
was not signiﬁcantly increased [Fig. 4(C)]. Co-treatment of
LY294002 could reduce the elevation in mRNA expression of
cadherin-11, VEGF-D, FGF-2. This data indicates that HP or TNF-a
induced cadherine-11 and VEGF-D expression was associated with
PI3K/Akt pathway.n SFs with pressure (90 kPa) or TNF-a stimulation (10 ng/ml) in absent (A) or present
¼ 3, and bars represent means with the 95% conﬁdence intervals. Exact P-values were
Fig. 5. Protein expression of cadherin-11, and other proteins related to PI3K/Akt pathways in SFs with HP (90 kPa) or TNF-a (10 ng/ml) with (B) or without (A) LY294002. A.
Western blot of Cadherin-11, P-Akt, Akt, VEGF-D, FGF-1, FGF-2, and GAPDH. B. Relative protein expressions of P-Akt. C. Relative protein expressions of Cadherin-11. D. Relative
protein expressions of VEGF-D. E. Relative protein expressions of FGF-2. The amount of each protein was determined densitometrically and normalized to GAPDH. Data shows all the
values from independent samples of n ¼ 3, and bars represent means with the 95% conﬁdence intervals. Exact P-values were computed compared to non-stimulated controls or cells
without LY294002 treatment.
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signaling event for angiogenesis20. We then determined whether
HP or TNF-a stimulation could regulate the phosphorylation-
dependent activation of PI3K/Akt. As shown in [Fig. 5(A)], West-
ern blot analyses revealed that treatment of SFs with HP and TNF-a
increased phosphorylation of PI3K. Increased expression of
phosphor-Akt was observed in SFs treated with 90 kPa HP or TNF-a
stimulation. To provide the further evidence, the speciﬁc PI3K in-
hibitor, LY294002 was used to incubate SFs with mechanical
loading or inﬂammatory stimulation. As shown in last three lanes
of [Fig. 5(A)], phosphorylation of Akt induced by HP and TNF-a
treatment was entirely inhibited by LY29400. We also tested the
effect of PI3K inhibitor on HP and TNF-a induced expression of
cadherin-11 and angiogenic factors VEGF-D and FGF-2. As shown in
[Fig. 5(C)], elevated expression of cadherin-11 by TNF-a was
signiﬁcantly attenuated after incubating with LY294002
(P ¼ 0.0107), while HP-induced increase of cadherin-11 was
moderately inhibited by LY294002 (P ¼ 0.0604). LY294002 treat-
ment also resulted in a signiﬁcant decrease of VEGF-D [Fig. 5(D)]
and FGF-2 [Fig. 5(E)] expression in both HP and TNF-a stimulation.
However, the level of FGF-1 was not signiﬁcantly affected by those
experimental conditions. These results suggested that PI3K/Akt was
involved in the intracellular signaling pathway of HP or inﬂam-
matory mediated production of cadherin-11.
Discussion and conclusion
TMD is a complex and multi-factorial disease, where physical,
social and psychological factors are usually associated with its eti-
ology21,22. Studies on etiological factors and molecular pathology of
TMD may lead to develop better treatment approaches. In this
study, we found that mRNA and protein expression of cadheirn-11
increased in SFs stimulated by either HP or TNF-a. This implies that
SFs following the mechanical stimuli and inﬂammatory reaction
may result in the invasion of SFs and destruction of cartilage. We
also found that the PI3K/Akt pathway was involved in themolecular signaling of SFs upon mechanical loading and inﬂam-
matory stimuli, due to induced phosphorylation of Akt during HP
and TNF-a treatment. The expression patterns of VEGF-D and FGF-2
were regulated in parallel to the expression of cadherin-11. More-
over, a PI3K/Akt inhibitor LY294002 could effectively attenuate the
increased expression of cadherin-11 and activation of Akt induced
by HP and TNF-a.
SFs are major components of the synovium in body joint, in
which cadherin-11 might be a dominant protein for the develop-
ment of arthritis23,24. Pressure overloading and inﬂammation are
the most important etiological factors in the pathogenesis of TMD.
To investigate the possible mechanism of cadherin-11 in SFs, we
mimicked themicro-environment of TMJ under pressure by HP. The
intra-articular pressure of TMJ may be varied according to time-
and spatial distributions of stresses induced by cartilage move-
ments such as mouth opening and clenching. Commonly used
mechanical loadings in vitro by different scholars include uncon-
ﬁned compression, semi-conﬁned compression, HP, and static or
intermittent pressure with a consideration of recovery periods25.
Each of those loading conditions mimics some aspects of the in vivo
mechanical behavior of articular cartilage in particular zones.
Because compressive HP correlates with regions of cartilage, HP
might be expected to serve as a stimulus for maintaining the sta-
bility of joint cavity. Therefore, HP was chosen to apply to the
cultured SFs in our study. According to the report of Nitzan DW,
intra-articular pressures of TMJ in 35 individuals ranged from þ8
to þ200 mmHg (approximate 26.6 kPa) while clenching26. TMJ is
always over-loaded, especially in case of poor chewing habits or
malocclusion27, suggesting higher pressure may be produced to
maintain the normal function of TMJ in TMD patients. Thus, the
magnitude of HP employed in the present study started from
30 kPa, which was close to the synovial ﬂuid HPmeasured in TMJ of
miniature pig with gradual mandibular advancement (220e
310 mmHg, approximate 30e41 kPa)28. Moreover, clinical evi-
dences suggested that excessive elevation of various cytokines such
as IL-1b, IL-6, and TNF-a in the synovial ﬂuid contribute to the onset
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lation and inﬂammatory response, which has been detected in the
synovium and synovial ﬂuid of patients with OA and RA31,32. Thus,
TNF-a (10 ng/ml) was chosen for representing inﬂammatory
stimulation in vitro, which was similar to previous reports14,18.
Cadherins, especially mesenchymal variants like cadherin-11,
are known to inﬂuence cell migration and invasion, which could
contribute to the regulation of arthritic tissue responses in both
acute and chronic synovitis33. Cadherin-11 is necessary for cellular
adhesion, compaction and matrix production of the synovial lining
in vivo, and lining layer compaction is an inherent feature of SFs
behavior that relies on cadherin-11 in vitro34. Many results suggest
that cadherin-11 is involved in mesenchymal tissue formation,
speciﬁcally in controlling the differentiation of these cells into os-
teoblasts and chondrocytes in past years35,36. In the present study,
we also found that themRNA and protein expression of cadherin-11
was positively related to the intensity of HP and the duration time
of TNF-a treatment in SFs from TMJ, while it can be suppressed by
the PI3K inhibitor. This ﬁnding provided novel evidence that
cadherin-11 was associated with signal transductionmolecules and
induction of intracellular messengers in SFs from TMJ, which was in
accordance with previous report that cell interaction mediated by
cadherin-11 induced the expression of VEGF-D in ﬁbroblasts37.
Changes in the cellular environment are known to affect local
adhesion complexes and modiﬁcation of the actin organization,
which may initiate downstream biosynthetic responses38. As an
endothelial cell-speciﬁc angiogenic factor, VEGF was commonly
used to determine potential cell migration and physiological or
pathological angiogenesis39,40. In the present study, we have found
the increased mRNA and protein expression of VEGF-D and FGF-2,
suggesting prompted angiogenesis in SFs with HP in vitro. Our
previous study also showed that expression of VEGF and other
related proteins were up-regulated in rat TMJ with mandibular
lateral shift41, which indicated mechanical loadings could activate
angiogenesis in vivo. Our ﬁnding was similar to previous report in
which evaluated VEGF was induced in chondrocytes in bovine
cartilage disks by mechanical overload42.
TMJ-OA and TMJ-RA are characterized by progressive joint
destruction with the different initiating factors. Previous studies
have shown that cartilage has decreased compressive and tensile
stiffness and may therefore be particularly sensitive to loading43,44.
Local inﬂammatory factors such as IL-1b, TNF-a, IL-18 trigger the
production of nitric oxide (NO) and prostaglandin E2 (PGE2), which
further promotes the pathological progression of RA45,46. Abnormal
mechanical loading and frequent mandibular movement of chew-
ing may result in various changes of the articular cavity. Actually,
the balance of environmental factors in joint cavity is important for
maintaining the survival of the SFs and chondrocytes, as well as the
stability of articular cartilage. Our ﬁndings implied that the balance
can be broken when expression of cadherin-11 gradually enhanced
along with the intensity of mechanical loading and the duration of
inﬂammation. Currently, the reorganization of damaged cartilage is
achieved by injection of growth factors attached in biodegradable
matrices, tissue transplantation and cellular engraftment47,48. Our
ﬁndings suggest that the PI3K/Akt signaling pathway may be an
interesting therapeutic target for treating joint diseases such as
TMJ-OA. LY294002 exhibited anti-angiogenic activity as well as
suppressing over-expression of cadherin-11 in the present study.
However, LY294002 is unsuitable for clinical use due to its toxicity.
Future work will be directed toward looking for the potential in-
hibitors of cadherin-11 for preventing the development of TMD.
In summary, this study provides new insights into the regula-
tory mechanisms of cadherin-11 in SFs from TMJ. Pressure and
inﬂammatory stimulation induced increase of cadherin-11 was
associated with PI3K/Akt pathway, which may be an importantpathogenetic factors in the development of TMD. Our ﬁndings
suggest that there may trigger a positive regulatory cycle whereby
mechanical loading and inﬂammation induces the transcription of
cadherin-11, VEGF, and ﬁbroblast growth factor (FGF) through PI3K/
Akt pathway.
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